TOP STORY
A fixed-dose combination of azilsartan medoxomil plus chlorthalidone (Edarbyclor, Takeda) was statistically superior to azilsartan medoxomil coadministered with hydrochlorothiazide at reducing and maintaining systolic blood pressure, according to the results of a phase 3 study published online August 31 in The American Journal of Medicine. » More |
Continuing Education
Welcome to a new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. This month, the professional development activity will cover the pathophysiology, diagnosis, screening, and risk factors associated with diabetes mellitus.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
TODAY'S HEADLINES
The new EpiPen 2-Pak holds two EpiPens plus a training pen, meant for training patients and their family members. In one hospital, however, a training pen was being stored in the emergency department's automated dispensing cabinet. » More |
|
A new technology add-on payment for Dificid (fidaxomicin) for Clostridium difficile-associated diarrhea was recently approved by the Centers for Medicare and Medicaid Services. » More
|
|
Mepolizumab significantly reduces asthma exacerbations in patients with severe eosinophilic asthma, according to a study published in the August 18 issue of The Lancet. » More
|
Survey
1. Barack Obama
2. Mitt Romney
3. I am not sure at this point
4. I don't plan on voting because I am not excited about any of the candidates
5. Other candidate
Respond here and see what your colleagues think too.
Want to see the results of our last survey about immunization schedules? Click here.
|
|
|
Like
Tweet
